Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment

NCT04338698 is registered in ClinicalTrials.gov with Shehnoor Azhar as lead sponsor.

NCT NCT04338698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04338698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment
Lead sponsor
Shehnoor Azhar
Phase
Phase 3
Overall status
Completed
Start date
April 22, 2020
Completion date
November 22, 2020
Enrollment
550 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19